Three prostate cancer patients have become the first people in Germany to be treated using a new, faster form of radiotherapy that potentially enables doctors to improve outcomes while extending more advanced care to more patients.
Greg Morrison gives a macro-view of what the facts and trends coming out of RNSA 2006 mean -- and he sees CT technology, in particular, moving into every area of both diagnostic imaging and therapy in a big way.
Commercial launch of AutovaxID™ will enable personalized cell-derived therapies.
74 percent of respondents say third-parties should be 'strictly regulated'
Mardil Medical appoints new member to Board of Directors
Reports so far show some gains versus placebo
A first look at the SOMATOM go.Now and SOMATOM go.Up
How the ACA altered the trajectory of innovation
Mammomat Fusion has advanced cesium-iodide detector for more efficient use of dose
Cost is a major hurdle but affordable solutions are emerging
